tac01-her2
triumvira,lonza,spdr s&p biotech,ishares biotechnology,triumvira
['tactic-2', 'tac01-her2', '$ibb', '$xbi']
triumvira immunologics presents promising clinical data on tac-01-her2 from tactic-2 trial at 2023 esmo world congress on gastrointestinal cancer. more info: $xbi $ibb $xph $pph 
BioPharma/Biotech Intel.  Daily $XBI $XPH Market Movers

Database: https://t.co/IBOqbSoYuc
Clinical trial tools: https://t.co/A77u9Q84Dc  http://globalclinicalt